ABSTRACT
ABSTRACT: The second of a two-part series, this article describes eight recently approved drugs, including the first drug approved for the treatment of SARS-CoV-2, a first-in-class HIV attachment inhibitor, and a new intravenous injection indicated for the treatment of acute pain in adults for whom other treatments are ineffective.
Subject(s)
Drug Approval , Adenosine Monophosphate/analogs & derivatives , Adenosine Monophosphate/therapeutic use , Alanine/analogs & derivatives , Alanine/therapeutic use , Amisulpride/therapeutic use , Carbamates/therapeutic use , Cephalosporins/therapeutic use , Chlorophenols/therapeutic use , Drug Combinations , Fumarates/therapeutic use , Humans , Indans/therapeutic use , Organophosphates/therapeutic use , Oxadiazoles/therapeutic use , Piperazines/therapeutic use , Spiro Compounds/therapeutic use , Tetrazoles/therapeutic use , Thiophenes/therapeutic use , Tromethamine/therapeutic use , United States , United States Food and Drug Administration , COVID-19 Drug Treatment , CefiderocolABSTRACT
ABSTRACT: This article reviews seven drugs recently approved by the FDA, including indications, precautions, adverse reactions, and nursing considerations.
Subject(s)
Drug Approval , Antibodies, Monoclonal, Humanized/therapeutic use , Benzamides/therapeutic use , Dicarboxylic Acids/therapeutic use , Fatty Acids/therapeutic use , Heterocyclic Compounds, 4 or More Rings/therapeutic use , Humans , Piperidines/therapeutic use , Pyridines/therapeutic use , Pyrimidines/therapeutic use , Pyrroles/therapeutic use , United States , United States Food and Drug AdministrationABSTRACT
This article reviews eight drugs recently approved by the FDA, including indications, precautions, adverse reactions, and nursing considerations.
Subject(s)
Drug Approval , Aminophenols/therapeutic use , Antibodies, Monoclonal, Humanized/therapeutic use , Azabicyclo Compounds/therapeutic use , Benzodioxoles/therapeutic use , Cilastatin/therapeutic use , Drug Combinations , Ethinyl Estradiol/therapeutic use , Genetic Vectors/therapeutic use , Humans , Imipenem/therapeutic use , Indoles/therapeutic use , Nitroimidazoles/therapeutic use , Pregnanolone/therapeutic use , Pregnenediones/therapeutic use , Pyrazoles/therapeutic use , Pyridines/therapeutic use , Pyrrolidines/therapeutic use , Quinolones/therapeutic use , Retinoids/therapeutic use , United States , United States Food and Drug Administration , beta-Cyclodextrins/therapeutic useABSTRACT
This article reviews seven drugs recently approved by the FDA, including indications, precautions, adverse reactions, and nursing considerations.
Subject(s)
Drug Approval , Antibodies, Monoclonal/therapeutic use , Benzofurans/therapeutic use , Carbamates/therapeutic use , Humans , Phenylalanine/analogs & derivatives , Phenylalanine/therapeutic use , Piperidines/therapeutic use , Purines/therapeutic use , Tetracyclines/therapeutic use , United States , United States Food and Drug AdministrationABSTRACT
This article reviews seven drugs recently approved by the FDA, including indications, precautions, adverse reactions, and nursing considerations.
Subject(s)
Drug Approval , Amifampridine/therapeutic use , Antibodies, Monoclonal/therapeutic use , Azetidines/therapeutic use , Benzyl Compounds/therapeutic use , Diterpenes/therapeutic use , Heterocyclic Compounds, 3-Ring/therapeutic use , Humans , Peptides, Cyclic/therapeutic use , Polycyclic Compounds/therapeutic use , Rifamycins/therapeutic use , Thioglycolates/therapeutic use , United States , United States Food and Drug Administration , alpha-MSH/therapeutic useABSTRACT
This article reviews nine drugs recently approved by the FDA, including indications, precautions, adverse reactions, and nursing considerations.
Subject(s)
Drug Approval , Aminopyridines , Cinnamates/therapeutic use , Factor Xa/therapeutic use , Humans , Macrolides/therapeutic use , Morpholines , Oligonucleotides/therapeutic use , Oxazines/therapeutic use , Pyridines/therapeutic use , Pyrimidines , RNA, Small Interfering/therapeutic use , Recombinant Proteins/therapeutic use , Sisomicin/analogs & derivatives , Sisomicin/therapeutic use , Tetracyclines/therapeutic use , Thiazoles/therapeutic use , Thiophenes/therapeutic use , United States , United States Food and Drug AdministrationABSTRACT
This article reviews seven drugs recently approved by the FDA, including indications, precautions, adverse reactions, and nursing considerations.
Subject(s)
Drug Approval , Aminoquinolines/therapeutic use , Antibodies, Monoclonal, Humanized/therapeutic use , Benzamides/therapeutic use , Cannabidiol/therapeutic use , Carbamates/therapeutic use , Dibenzothiepins , Humans , Morpholines , Oxazines/therapeutic use , Pyridines/therapeutic use , Pyridones , Thiepins/therapeutic use , Triazines/therapeutic use , United States , United States Food and Drug AdministrationABSTRACT
This article reviews eight drugs recently approved by the FDA, including indications, precautions, adverse reactions, and nursing considerations.
Subject(s)
Drug Approval , Amides , Angiotensin II/therapeutic use , Antibodies, Monoclonal/therapeutic use , Antibodies, Monoclonal, Humanized , Azetidines/therapeutic use , Clonidine/analogs & derivatives , Clonidine/therapeutic use , Heterocyclic Compounds, 3-Ring , Heterocyclic Compounds, 4 or More Rings/therapeutic use , Humans , Hydrocarbons, Fluorinated/therapeutic use , Piperazines , Purines , Pyrazoles , Pyridones , Pyrimidines/therapeutic use , Silicates/therapeutic use , Sulfonamides/therapeutic use , United States , United States Food and Drug AdministrationABSTRACT
This article reviews seven drugs recently approved by the FDA, including indications, precautions, adverse reactions, and nursing considerations.
Subject(s)
Drug Approval , Aminophenols/therapeutic use , Aminopyridines/therapeutic use , Antibodies, Monoclonal, Humanized/therapeutic use , Benzoates/therapeutic use , Benzodioxoles/therapeutic use , Bridged Bicyclo Compounds, Heterocyclic/therapeutic use , Drug Combinations , Glucagon-Like Peptides/therapeutic use , Humans , Indoles/therapeutic use , Quinolones/therapeutic use , United States , United States Food and Drug Administration , beta-Alanine/analogs & derivatives , beta-Alanine/therapeutic use , cis-trans-Isomerases/therapeutic useABSTRACT
This article discusses eight drugs recently approved by the FDA, including their indications and contraindications, precautions, dosage, and nursing considerations. The article also includes summary charts on 14 recently approved antineoplastic drugs and four drugs approved for rare disorders.
Subject(s)
Drug Approval , Acetates/therapeutic use , Boronic Acids/therapeutic use , Drug Combinations , Fluoroquinolones/therapeutic use , Humans , Meropenem , Metronidazole/analogs & derivatives , Metronidazole/therapeutic use , Nitroimidazoles/therapeutic use , Parathyroid Hormone-Related Protein/therapeutic use , Peptides/therapeutic use , Prostaglandins F, Synthetic/therapeutic use , Quinazolines/therapeutic use , Thienamycins/therapeutic use , United States , United States Food and Drug AdministrationABSTRACT
Five new drugs marketed within the last year, which are used for medical problems often experienced by the elderly, have been selected for consideration in this review. The uses and most important properties of these agents are discussed, and a rating for each new drug is determined using the New Drug Comparison Rating system developed by the author (DAH). Advantages, disadvantages, and other important information regarding each new drug are identified and used as the basis for determining the rating. The drugs include an anticoagulant, an antiparkinson agent, an agent for tardive dyskinesia, an agent for psoriasis, and an agent for constipation. The drugs reviewed are betrixaban, safinamide mesylate, valbenazine tosylate, guselkumab, and plecanatide.
Subject(s)
Drug Approval , Aged , Alanine/analogs & derivatives , Alanine/therapeutic use , Antibodies, Monoclonal/therapeutic use , Antibodies, Monoclonal, Humanized , Anticoagulants/therapeutic use , Antiparkinson Agents/therapeutic use , Benzamides/therapeutic use , Benzylamines/therapeutic use , Constipation/drug therapy , Humans , Natriuretic Peptides/therapeutic use , Psoriasis/drug therapy , Pyridines/therapeutic use , Tardive Dyskinesia/drug therapy , Tetrabenazine/analogs & derivatives , Tetrabenazine/therapeutic use , Valine/analogs & derivatives , Valine/therapeutic useABSTRACT
Five new drugs marketed within the last year that are used for medical problems often experienced by the elderly have been selected for consideration in this review. The uses and most important properties of these agents are discussed, and a rating for each new drug is determined using the New Drug Comparison Rating system developed by the author (DAH). Advantages, disadvantages, and other important information regarding each new drug are identified and used as the basis for determining the rating. The drugs include two antidiabetic agents, an agent for gout, an antipsychotic agent, and a drug for dry eye disease.
Subject(s)
Anti-Inflammatory Agents/therapeutic use , Antipsychotic Agents/therapeutic use , Drugs, Investigational/therapeutic use , Gout Suppressants/therapeutic use , Hypoglycemic Agents/therapeutic use , Anti-Inflammatory Agents/adverse effects , Antipsychotic Agents/adverse effects , Drugs, Investigational/adverse effects , Dry Eye Syndromes/drug therapy , Gout Suppressants/adverse effects , Humans , Hypoglycemic Agents/adverse effects , Insulin, Long-Acting/therapeutic use , Peptides/therapeutic use , Phenylalanine/analogs & derivatives , Phenylalanine/therapeutic use , Piperidines/therapeutic use , Sulfones/therapeutic use , Thioglycolates/therapeutic use , Triazoles/therapeutic use , Urea/analogs & derivatives , Urea/therapeutic useABSTRACT
Six new drugs marketed within the last year, which are used for medical problems often experienced by the elderly, have been selected for consideration in this review. The uses and most important properties of these agents are discussed, and a rating for each new drug is determined using the New Drug Comparison Rating (NDCR) system developed by the author. Advantages, disadvantages, and other important information regarding the new drug are identified and used as the basis for determining the rating. The drugs include a hypnotic, an anticoagulant, two drugs for heart failure, and two drugs to reduce low-density lipoprotein cholesterol.
Subject(s)
Anticholesteremic Agents/therapeutic use , Anticoagulants/therapeutic use , Heart Failure/drug therapy , Hypnotics and Sedatives/therapeutic use , Aged , Drug Approval , Humans , United StatesSubject(s)
Pregnanolone , beta-Cyclodextrins , Azetidines , Benzyl Compounds , Biological Products , Drug Combinations , Humans , Recombinant Fusion ProteinsSubject(s)
Sodium , Aminophenols , Azabicyclo Compounds , Benzodioxoles , Cilastatin, Imipenem Drug Combination , Humans , Indoles , Nitroimidazoles , Pyrazoles , Pyridines , Pyrrolidines , QuinolonesABSTRACT
Six new drugs approved within the last two years, which are used for medical problems often experienced by the elderly, have been selected for consideration in this review. The uses and most important properties of these agents are discussed, and a rating for each new drug is determined using the New Drug Comparison Rating system developed by the author. Advantages, disadvantages, and other important information regarding the new drug are identified and used as the basis for determining the rating. The drugs include two antidiabetic agents, one bronchodilator, one antidepressant, one for erectile dysfunction, and one for menopause-associated conditions.